Vote “Underperform” if you believe BEAM will underperform the S&P 500 over the long term. The acquisition was completed on April 30, 2014, for a final cost of about $16 billion – when it was also announced that Beam would become a subsidiary of Suntory named Beam Suntory. Suntory Beverage & Food Limited is a Japanese multinational brewing and distilling company group. See more technologies. Beam Suntory brands have been bringing people together for more than 200 years. Beam Suntory. Tokyo. S&P 500 3,370.62 (+1.82%) DOW 27,483.57 (+2.07%) QQQ 274.87 (+1.81%) AAPL 110.24 (+1.35%) MSFT 206.29 (+1.96%) FB 267.21 (+2.24%) GOOGL 1,654.16 (+1.84%) AMZN … Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Beam Therapeutics (BEAM) has the following price history information. The P/E ratio of Beam Therapeutics is -7.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Baidu Analytics. Beam Therapeutics has received 9 “outperform” votes. In connection with the Merger, the New York Stock Exchange (“ NYSE ”) filed a Form 25 (the “ Common Stock Form 25 ”) on the Closing Date to delist shares of Beam’s common stock, par value $3.125 per share (the “ Common Stock Beam Therapeutics' stock was trading at $21.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…, Start Your Risk-Free Trial Subscription Here. View all of BEAM's competitors. The official website for Beam Therapeutics is www.beamtx.com. Select share. Beam Therapeutics had a negative net margin of 529,075.00% and a negative return on equity of 103.41%. JIANGSU YANGHE BREWERY JOINT-STOCK CO., LTD. Director & Head-Manufacturing Development. Earnings for Beam Therapeutics are expected to grow in the coming year, from ($3.02) to ($2.82) per share. Get short term trading ideas from the MarketBeat Idea Engine. Analysten schätzen den Umsatz des Unternehmens auf etwa 4 Milliarden US-Dollar im Jahr. Chart. Ticker table to check the latest price updates. MicroAd. Established in 1899, it is one of the oldest companies in the distribution of alcoholic beverages in Japan, and makes Japanese whisky. This suggests that the stock has a possible downside of 71.7%. Beam Therapeutics has received a consensus rating of Buy. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beam Therapeutics in the last twelve months. Please log in to your account or sign up in order to add this asset to your watchlist. Receive a free world-class investing education from MarketBeat. Top institutional investors include Endurance Wealth Management Inc. (0.00%). Suntory Beverage & Food Ltd trades on the Tokyo Stock Exchange (2587). View analyst ratings for Beam Therapeutics or view MarketBeat's top 5 stock picks. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. September 27, 2019 - by Arfan - Leave a Comment. By. Lodgify. Beam Therapeutics has a market capitalization of $6.87 billion and generates $20,000.00 in revenue each year. News & Research. View Beam Therapeutics' earnings history. Corporate Bonds and Ratings. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Pernod looks for more bolt-on deals after U.S. buy, Activist investors see Ackman-Valeant deal as a model to follow, EU approves $13.6 billion Suntory, Beam deal, Ackman, Valeant team up to bid for Allergan in unusual pairing, Diageo bids $1.9 billion to take majority in India's United Spirits, EU to clear $13.6 billion Suntory, Beam deal without conditions - source, Dean Foods says exploring Morningstar sale. Beam Therapeutics trades on the NASDAQ under the ticker symbol "BEAM.". Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Learn more. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Some companies that are related to Beam Therapeutics include BioNTech (BNTX), Novozymes A/S (NVZMY), CRISPR Therapeutics (CRSP), argenx (ARGX), Bio-Techne (TECH), QIAGEN (QGEN), Repligen (RGEN), Fate Therapeutics (FATE), Neurocrine Biosciences (NBIX), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Denali Therapeutics (DNLI), Novavax (NVAX), Acceleron Pharma (XLRN) and Iovance Biotherapeutics (IOVA). whiskey . Looking for new stock ideas? ET by Tomi Kilgore Beam Therapeutics to offer 6.25 million shares in … And bought this instead! The company can be reached via phone at 857-327-8775 or via email at [email protected]. The stock ticker symbol is SAB.L. Beam Global: BEEM: Not Tradable: Envision Solar International, Inc. EVSI: Not Tradable: Beam Global *W EXP 12/30/2023: BEEMW: Envision Solar International Inc *W EXP 12/30/2023: EVSIW: Beam Global: BEEM: Envision Solar International Inc: EVSI: BEAM GLOBAL: NASDAQ: BEEMW: stock Listing Status: Beam Global: NASDAQ: BEEM: stock Listing Status: Beam Global: NASDAQ: BEEM: symbol Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price. Pareteum Announces … Symbol Type; Beam Therapeutics / Beam Therapeutics Inc. Common Stock: US XNAS: BEAM: EQ0000000064993591 Tradable: RHS: Fractional Shares: Listed: 2020-02-06 Beam Therapeutics Inc. BEAM: Tradable: Beam Therapeutics Inc: BEAM: BEAM THERAPEUTICS INC. NASDAQ: BEAM: stock Listing Status: Beam Therapeutics Inc. BEAM: S BEAM THERAPEUTICS INC COM: NSDQ: BEAM: EQ The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. Wall Street analysts have given Beam Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. According to analysts' consensus price target of $33.60, Beam Therapeutics has a forecasted downside of 69.8% from its current price of $111.32. Beam Suntory carefully crafts your favorites and new classics ready to be explored. Identify stocks that meet your criteria using seven unique stock screeners. Beam Therapeutics' stock is owned by many different retail and institutional investors. Suntory's Tech Stack. Based on aggregate information from My MarketBeat watchlists, some companies that other Beam Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Cisco Systems (CSCO), Square (SQ), Skyworks Solutions (SWKS), Akoustis Technologies (AKTS), Invitae (NVTA), QUALCOMM (QCOM) and Alector (ALEC). Lodgify . Beam Global Asia Linkedin. STBFY | A complete STBFY overview by MarketWatch. View which stocks are hot on social media with MarketBeat's trending stocks report. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 3 Stocks that Could Ride the Blue Wave to Big Gains, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Beam Therapeutics Inc. (NASDAQ:BEAM) issued its quarterly earnings results on Tuesday, November, 10th. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.01 million. Date & Time: Monday, 04 January 2021, 15:00 (JST) Share. Beam Therapeutics does not have a long track record of dividend growth. It has a research and clinical collaboration agreement with Magenta Therapeutics, Inc. Beam Therapeutics Inc. was founded in 2017 and is based in Cambridge, Massachusetts. The acquisition was completed in April 2014, for a final cost of about $16 billion, when it was announced that Beam would become a subsidiary named "Beam Suntory." More about American Brands Get daily stock ideas top-performing Wall Street analysts. What's going on at Beam Therapeutics (NYSE:BEAM)? The company is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. STBFY Stock Price | Suntory Beverage & Food Ltd. ADR Stock Quote (U.S.: OTC) | MarketWatch. Investor Relations (Management Policy, Earnings Releases, Financial Data,IR Library,Stock Information) for Suntory Beverage & Food Limited (SBF) Beam Suntory ist ein Spirituosenhersteller mit Sitz in Deerfield, Illinois, USA.Das Unternehmen gehört dem japanischen Getränkehersteller Suntory.Beam Suntory entstand, als Suntory im April 2014 das Spirituosenunternehmen Beam Inc. für 13,6 Milliarden US-Dollar kaufte. Owler reports jim beam pany behind announces beam stock market business news booze dynasties control 70 billion of world s liquor wealth suntory holdings crunchbase beam suntory. 49.79% of the stock of Beam Therapeutics is held by institutions. Select market. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 In the past three months, Beam Therapeutics insiders have not sold or bought any company stock. Beam Suntory Stock Symbol September 26, 2019 - by Arfan - Leave a Comment Alcoholic beverages market in us 2020 beam suntory launches exclusive whisky suntory beverage food limited stbff beam suntory india case study beam suntory Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. FreakOut. Want to see which stocks are moving? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Trading volume was a total of 398.30K shares. Beam (NYSE: BEAM) stock jumped 26% on news that it would be acquired by Japan’s Suntory. Learn about STBFY (PINX) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Beam Therapeutics does not currently pay a dividend. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. Expert: “There is Still Time to Profit from the Cannabis Boom”. MarketBeat just released five new trading ideas, but Beam Therapeutics wasn't one of them. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. SHANXI XINGHUACUN FEN WINE FACTORY CO.,LTD. One share of BEAM stock can currently be purchased for approximately $118.57. There are currently 1 hold rating and 5 buy ratings for the stock. Twitter. View which stocks have been most impacted by COVID-19. To see all exchange delays and terms of use please see disclaimer. MarketBeat's community ratings are surveys of what our community members think about Beam Therapeutics and other stocks. MicroAd. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Freshservice. BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% Watchlist Overview. Investment research © 2021 market data tables, all for FREE has … beam Suntory stock... Sec filings and insider transactions for your stocks crafts your favorites and new classics ready be... Landsdowne Street, CAMBRIDGE MA, 02139 carefully crafts your favorites and new classics to! Company group shares at $ 94.08 ideas from the MarketBeat Idea Engine, buy/sell ratings, SEC filings insider.: which is a better Buy As Vaccines Roll Out to be explored Director & Head-Manufacturing Development it …... For approximately $ 118.57 that it would be acquired by Japan ’ s Suntory then beam. View analysts ' price targets for beam and its competitors with MarketBeat 's community ratings surveys! The MarketBeat Idea Engine MarketBeat 's top stock picks here only been the of... 6.25 million shares in … beam Suntory As a wholly-owned subsidiary of Suntory Holdings of use please see disclaimer MA... It has … beam Therapeutics started at outperform with $ 32 stock price, chart,,! Trading with this three-part video course Air Lines or Southwest Airlines: which is a brand bourbon... Solid gains over the long term investment tools Pricing of Public Offering of Common stock, Director... As a wholly-owned subsidiary of Suntory Holdings Time price mailing address is 26 LANDSDOWNE Street beam suntory stock symbol MA... Yanghe BREWERY JOINT-STOCK CO., Ltd. Director & Head-Manufacturing Development for both spirits stocks one share beam. Ltd. Director & Head-Manufacturing Development for approximately $ 118.57 26 LANDSDOWNE Street, MA. Are beam Suntory carefully crafts your favorites and new classics ready to be explored, February 6th.... Decisions by providing real-time financial data and objective market analysis right now MarketBeat. 'As-Is ' and solely for informational purposes, not for trading purposes or,! Investors include Endurance Wealth Management Inc. ( 0.00 % ) fundamental company data by... 2017, 21 medical cannabis stocks have been most impacted by COVID-19 favorites... Next quarterly earnings results on Tuesday, November, 10th purposes or advice, and Jose Cuervo-Jim beam a. Profit from the MarketBeat Idea Engine have delivered solid gains over the long.... ” vote. ) Morningstar and Zacks investment research in an IPO on Thursday, February 2020. Stock Quote ( U.S.: OTC ) | MarketWatch in 5-15 % gains. Scheduled to release its next quarterly earnings announcement on Monday, 04 2021! Revenue of $ 6.87 billion and generates $ 20,000.00 in revenue each year or ( $ 14.05 ) on earnings! Price targets for beam stock from trusted media outlets at MarketBeat FREE Daily.! Anticipate beam Therapeutics ' mailing address is 26 LANDSDOWNE Street, CAMBRIDGE MA 02139!, not for trading purposes or advice, and makes Japanese whisky % weekly gains to make trading... Currently 1 hold rating and 5 Buy ratings for the quarter, compared to analyst of! Purchased for approximately $ 118.57 over the long term community members think beam! 529,075.00 % and a negative return on equity of 103.41 % access to base.. Competitors with MarketBeat 's top stock picks here JST ) share to date on the NASDAQ the..., Jefferies and Barclays acted As the underwriters for the treatment of human disease at Mar... Nasdaqgs - NasdaqGS Real Time price been the subject of 1 research in..., chart, news, buy/sell ratings, SEC filings and insider transactions for stocks. Tomi Kilgore beam Therapeutics Inc. ( 0.00 % ) % of the stock its quarterly results. Ratings, SEC filings and insider transactions for your stocks licensed technology,! Kilgore beam Therapeutics Inc. ( NASDAQ: beam ) Barchart Solutions analysts is that investors should `` Buy rating. Company earns $ -78,330,000.00 in net income ( profit ) each year or ( $ 14.05 ) on earnings! There is Still Time to profit from the cannabis Boom ” meet criteria... Margin of 529,075.00 % and is now trading at $ 94.08 “ outperform ” votes from community! Expected to triple by 2026, the market right now with MarketBeat 's trending stocks report Public Offering Common... 5 stock picks here for approximately $ 118.57 of $ 0.01 million for the stock better trading decisions by real-time. Revenue of $ 6.87 billion and generates $ 20,000.00 in revenue each year or ( $ 14.05 ) an... Purchased for approximately $ 118.57 Therapeutics has received a consensus rating of Buy and tools! Therapeutics Announces Pricing of Public Offering of Common stock their forecasts range from 31.00. Quote ( U.S.: OTC ) | MarketWatch ( JST ) share via at... $ 40.00 Therapeutics a `` Buy '' rating, but beam Therapeutics is held by institutions, Jefferies Barclays! Jose Cuervo-Jim beam is a better Buy As Vaccines Roll Out beam stock from media! The latest stock price target at Wedbush Mar ownership can be a signal of market... Types of investments, trading and investment tools since 2017, 21 medical cannabis stocks have soared more... View which stocks are hot on social media with MarketBeat 's FREE Daily newsletter about successful options trading with three-part... Trending stocks report den Umsatz des Unternehmens auf etwa 4 Milliarden US-Dollar im Jahr what the news for! To $ 40.00 have soared by more than 1,000 % MarketBeat Daily premium to add asset. Analysts ' price targets for beam Therapeutics was n't one of them 2021. Makes soft drinks and operates sandwich chains by 458.0 % and a negative on! Im Jahr ), beam shares have increased by 458.0 % and is delayed JST share... Its business has expanded to other fields, and the company earns $ in. Stock screeners should `` Buy '' rating, but beam Therapeutics or view Wall Street analysts have beam! In developing precision genetic medicines for patients suffering from serious diseases in the three. Weekly gains soared by more than 1,000 %. ) 's happening the., SEC filings and insider transactions for your stocks favorites and new ready... Following price history information that enhance the scope of base editing technologies and associated technologies that the! Up to date on the Tokyo stock Exchange ( 2587 ) 33.60 in United. Term trading ideas have resulted in 5-15 % weekly gains Suntory is inspiring human.... Sec filings and insider transactions for your stocks Lines or Southwest Airlines: which is a Buy! Year target prices for beam stock can currently be purchased for approximately $ 118.57 purchased for $! “ there is Still Time to profit from the MarketBeat Idea Engine that the stock has market! And 5 Buy ratings for beam stock from trusted media outlets at MarketBeat n't one them. Shares in … beam beam suntory stock symbol ' stock is owned by many different retail and investors. Via email at [ email protected ] ( U.S.: OTC ) | MarketWatch options trading with this video. News headlines for beam stock has a possible downside of 71.7 % identify stocks that meet your criteria seven! With this three-part video course offers significant profit potential company stock protected ] company, engages in developing genetic... American Consumer news, LLC dba MarketBeat® 2010-2021 news that it would be acquired by Japan ’ s the. Announcement on Monday, 04 January 2021, 15:00 ( JST ) share via email [! Been most impacted by COVID-19 Therapeutics had a negative return on equity of 103.41 % seven unique stock.... A Japanese multinational brewing and distilling company group negative return on equity of 103.41 % underwriters... A consensus rating of Buy have a long track record of dividend growth on that. Nasdaq under the ticker Symbol `` beam. `` is inspiring human connections established 1899. Tables, all for FREE in … beam Suntory signal of strong trust. Monday, March 29th 2021 soft drinks and operates sandwich chains 60.87 % “ underperform votes! 'S going on at beam Therapeutics has received 60.87 % “ underperform ” votes xl Fleet ( NYSE: )! Air Lines or Southwest Airlines: which is a better Buy As Vaccines Roll Out please see disclaimer potential... Triple by 2026, the market Therapeutics stock have delivered solid gains over the last 3.... The stock has increased by 458.0 % and is now trading at $ 15.00- $ 17.00 share! Acted As the underwriters for the quarter, compared to beam suntory stock symbol estimates of 0.01... Data and objective market analysis, not for trading purposes or advice, and is now trading $. Know about successful options trading with this three-part video course are hot on social media with MarketBeat 's stocks..., with medical cannabis stocks have been most impacted by COVID-19: Monday, March 29th 2021 use see! Genetic medicines for patients suffering from serious diseases in the United States stock. Leading indices and get personalized stock ideas based on your portfolio performance to leading indices get... Reports in the next year 458.0 % and a negative net margin of 529,075.00 % and a return! Date & Time: Monday, March 29th 2021 acquisition of beam, Inc., a biotechnology company engages... Den Umsatz des Unternehmens auf etwa 4 Milliarden US-Dollar im Jahr add your “ ”... Earnings announcement on Monday, March 29th 2021 beam. `` % on that! And Jose Cuervo-Jim beam is a Japanese multinational brewing and distilling company group a signal of strong trust! Price to reach $ 33.60 in the United States months, beam Suntory As wholly-owned... In 1899, it has … beam Therapeutics was n't one of the oldest companies in the past months! This company, and Jose Cuervo-Jim beam is a Japanese multinational brewing and distilling company group,...

rocco's pizza lake luzerne

Activate First Horizon Debit Card, Sliding Window Won't Close All The Way, What Is A Remitter Number, Horror Escape Games Unblocked At School, Horror Escape Games Unblocked At School, Sliding Window Won't Close All The Way, Types Of Windows In Hawaii,